•Transient receptor potential vanilloid channels in inflammatory bowel diseases: linking inflammation, angiogenesis, and oxidative stress
•Clinical characteristics and risk factor analysis of EBV and CMV infection in the patients with inflammatory bowel disease
•Physiologically Based Pharmacokinetic Modeling of Vedolizumab in Healthy Adults and Patients with Inflammatory Bowel Disease
•Metabolic Dysfunction-Associated Steatotic Liver Disease in Inflammatory Bowel Disease: A Cross-Sectional Study of Prevalence and Associated Factors
•TET Enzymes as Epigenetic Integrators in Intestinal Immunity, Inflammation, and Disease